SB1518, a novel JAK2/FLT3 inhibitor for the treatment of myeloid malignancies

被引：0

作者：

Hart, Stefan ^{[1
]}

Goh, Kee Chuan ^{[1
]}

Novotny-Diermayr, Veronica Veronica ^{[1
]}

Tan, Yong Cheng ^{[1
]}

Madan, Babita ^{[1
]}

Amalini, Chithra ^{[1
]}

Loh, Yung Kiang ^{[1
]}

Ong, Lai Chun ^{[1
]}

Williams, Anthony ^{[1
]}

Lee, Angeline ^{[1
]}

Poulsen, Anders ^{[1
]}

Jayaraman, Ramesh ^{[1
]}

Ethirajulu, Kantharaj ^{[1
]}

Dymock, Brian W. ^{[1
]}

Wood, Jeanette M. ^{[1
]}

机构：

[1] S BIO PTE LTD, Singapore, Singapore

来源：

CANCER RESEARCH | 2011年 / 71卷

关键词：

D O I：

10.1158/1538-7445.AM2011-3570

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3570

引用

页数：1

共 50 条

[21] The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML
Novotny-Diermayr, V.
Hart, S.
Goh, K. C.
Cheong, A.
Ong, L-C
Hentze, H.
Pasha, M. K.
Jayaraman, R.
Ethirajulu, K.
Wood, J. M.
BLOOD CANCER JOURNAL, 2012, 2 : e69 - e69
[22] The Effects of SB1518, a Novel Oral JAK2 Inhibitor, On Ex Vivo Expanded PV Erythroid Progenitors Correlate with Clinical Observations
Goh, Kee Chuan
Hart, Stefan
Tan, Yong Cheng
Chithra, Amalini
Ong, Kiat H.
Wood, Jeanette
BLOOD, 2009, 114 (22) : 1138 - 1138
[23] PHASE 1 STUDY OF A NOVEL ORAL JAK2 INHIBITOR, SB1518, IN PATIENTS WITH RELAPSED LYMPHOMA: EVIDENCE OF CLINICAL AND BIOLOGIC ACTIVITY IN MULTIPLE LYMPHOMA SUBTYPES
Younes, A.
Fanale, M.
Mclaughlin, P.
Copeland, A.
Faria, S. De Castro
Zhu, J.
ANNALS OF ONCOLOGY, 2011, 22 : 136 - 137
[24] The Effects of Vitamin A Intake and FLT3/JAK2 Inhibition on FLT3-Mutated Acute Myeloid Leukemia Cells as Potential Novel Treatment Options
Swanson, Lainee
Sharp, Jonathan
Kadmiel, Mahita
Duriancik, David
JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S574 - S574
[25] Pacritinib, a Dual FLT3/JAK2 Inhibitor, Reduces Irak-1 Signaling in Acute Myeloid Leukemia
Cleary, Megan M.
Thompson, Rhese
Mahmood, Shawn
Davare, Monika
Kurtz, Steve
Elferich, Johannes
Shinde, Ujwal
Druker, Brian J.
Singer, Jack
Agarwal, Anupriya
BLOOD, 2015, 126 (23)
[26] Flonoltinib, a Novel JAK2/FLT3 Inhibitor, Potently Treats Hemophagocytic Lymphohistiocytosis and Increases Sensitivity to Dexamethasone
Zhao, Ailin
Wang, Xin
Hu, Mengshi
Chen, Lijuan
Niu, Ting
BLOOD, 2022, 140 : 2624 - 2625
[27] 2-Aminopyrimidine derivatives as selective dual inhibitors of JAK2 and FLT3 for the treatment of acute myeloid leukemia
Xu, Sicong
Zhu, Yiran
Meng, Jie
Li, Chao
Zhu, Zhenzhen
Wang, Chen
Gu, Yu-Cheng
Han, Liang
Wen, Jiajie
Tong, Minghui
Shi, Xuan
Hou, Yunlei
Liu, Yajing
Zhao, Yanfang
BIOORGANIC CHEMISTRY, 2023, 134
[28] Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2V617F-induced myeloproliferative neoplasms
Hu, Mengshi
Yang, Tao
Yang, Linyu
Niu, Lu
Zhu, Jinbing
Zhao, Ailin
Shi, Mingsong
Yuan, Xue
Tang, Minghai
Yang, Jianhong
Pei, Heying
Yang, Zhuang
Chen, Qiang
Ye, Haoyu
Niu, Ting
Chen, Lijuan
BLOOD CANCER JOURNAL, 2022, 12 (03)
[29] Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3)
Anders Poulsen
Anthony William
Stéphanie Blanchard
Angeline Lee
Harish Nagaraj
Haishan Wang
Eeling Teo
Evelyn Tan
Kee Chuan Goh
Brian Dymock
Journal of Computer-Aided Molecular Design, 2012, 26 : 437 - 450
[30] Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3)
Poulsen, Anders
William, Anthony
Blanchard, Stephanie
Lee, Angeline
Nagaraj, Harish
Wang, Haishan
Teo, Eeling
Tan, Evelyn
Goh, Kee Chuan
Dymock, Brian
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2012, 26 (04) : 437 - 450

← 1 2 3 4 5 →